$1.84
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 118 full-time employees. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Country

US

CEO

Dr. Peter Beetham

IPO date

2017

Employees

118

ISIN

US17166A1016

Key stats

Open

$1.90

Volume

856.11K

Market cap

$138.92M

Prev. close

$1.90

Impl / hst vl

-

Open interest

$0.00

$1.84

Day’s Range

$1.90

$1.17

52W Range

$4.19

Valuation

11
Valuation score
Strongly Overvalued
P/E
-
P/S
30.44
P/B
3.68
Current ratio
2.37
Debt / Equity
6.03
ROE
-225.59%
Gross margin
-
Income growth
-32.17%
FCF growth
-14.10

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$14.96
The top 5 analysts forecasts that 12-month price may increase by 713.05%, with a low of $3.03 and a high of $26.25
$3.03
Low
$14.96
Avg
$26.25
High
Current price

Earnings

Q1 ‘26 revenue
$1.68M
Q1 ‘26 net income
-$21.22M
Revenue
Net income
Previous EPS
-$0.33
Estimate EPS
-$0.31
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply